MIG AG

CoreMedic AG is a medical technology company based in Biel/Bienne, Switzerland, specializing in the development and manufacturing of devices and therapies for heart valve diseases, particularly mitral valve regurgitation. Founded in 2012 as a spin-out from the Heart Center of the University of Bern, the company has created the ChordArt system, which offers a minimally invasive approach for repairing mitral valves. This system includes ChordArt S, designed to streamline the surgical procedure by allowing surgeons to focus on timing rather than manual suturing, and ChordArt C, which enables repairs through a small incision in the groin. Following successful human trials, CoreMedic is committed to advancing the ChordArt transcatheter mitral valve repair system to improve treatment options for patients suffering from severe mitral regurgitation. The company is positioned within a prominent medical technology cluster in Germany, facilitating collaboration and innovation in the field.

Liva Healthcare is a digital health coaching platform focused on scalable lifestyle and disease management, particularly for chronic conditions such as Type 2 diabetes, obesity, and heart disease. The company provides an intuitive app that fosters personalized health coaching, creating strong connections between coaches, general practitioners, and patients. Its platform is designed to engage patients over nine to 18 months, promoting sustainable behavior change and habit formation. Liva Healthcare's services are utilized by various organizations, including public healthcare systems and private insurers. The app is multilingual and effective across diverse socio-economic groups, allowing one coach to manage up to 500 patients simultaneously. Implementation typically occurs within weeks, and the platform is offered as both a white-label Software as a Service solution and a turn-key option, tailored to client needs. Liva Healthcare operates from offices in Copenhagen, Denmark, and London, UK.

Inbolt specializes in developing advanced vision systems for industrial robots, aimed at enhancing decision-making capabilities in various environments. By utilizing artificial intelligence and 3D vision, Inbolt's technology provides adaptive real-time guidance for robots, allowing them to operate more intelligently. Additionally, the company's vision-based tools facilitate the automation of complex tasks in unstructured settings, offering real-time quality control for manual operations like torquing, drilling, and riveting. This innovation not only reduces the incidence of faulty operations but also significantly improves overall quality control in industrial processes.

SciRhom GmbH is a biotech company focused on the preclinical and early clinical development of novel biopharmaceuticals aimed at treating life-threatening autoimmune diseases. Founded in 2016 through collaboration between academic and industry scientists with expertise in antibody development, SciRhom leverages extensive research and a network of specialists to advance its therapeutic offerings. The company develops therapeutic antibodies targeting iRhom2, a significant modulator of key pro-inflammatory signaling pathways, including TNF-alpha. This approach seeks to enhance treatment options for patients suffering from severe autoimmune conditions, particularly those affecting the skin and intestinal barriers.

Innatera is an innovative developer of ultra-low power neuromorphic processors designed to enhance the efficiency of sensor data processing. Established in 2018 as a spin-off from the Delft University of Technology, the company focuses on creating processors that replicate the brain's mechanisms for sensory perception. Utilizing a novel continuous-time analog-mixed signal processing architecture, Innatera's chips can process sensor data up to 100 times faster while consuming up to 500 times less energy compared to traditional processors. This technology enables businesses to access and analyze sensor data more effectively, positioning Innatera as a leader in the field of energy-efficient computing solutions.

HawkCell is a medical research company specializing in advanced magnetic resonance imaging (MRI) solutions for veterinary clinics and preclinical research laboratories. The company utilizes a non-ionizing three-dimensional (3D) imaging approach, employing specialized MRI sensors designed to accommodate various animal morphologies. By adapting human MRI technology for animal diagnostics, HawkCell provides sustainable systems enhanced with artificial intelligence algorithms. This innovation allows veterinary clinics and research labs to obtain precise and insightful imaging, facilitating improved animal healthcare and scientific exploration.

Look Up Space specializes in providing high-quality space safety and security data and services designed to assist organizations in effectively managing space-related risks. The company utilizes a dedicated, sovereign sensor network combined with advanced data processing capabilities to deliver real-time information. This approach enables businesses to access critical data that supports their growth while simplifying the complexities associated with space safety and security.

AMSilk GmbH, founded in 2008 and based in Munich, Germany, specializes in producing spider silk proteins and other biomaterials for various industrial applications. The company offers a range of products, including BioShield-S1, a non-immunogenic spider silk film for protective coatings, and biosteel spider silk fibers. Additionally, AMSilk provides wound care products such as SanaSilk, designed to protect the skin, and spider silk-based solutions for surgical applications. Their product portfolio also includes spider silk protein beads and coatings for medical technology, as well as nonwovens for use in filters, wound dressings, and specialty textiles. AMSilk serves multiple sectors, including pharmaceuticals, cosmetics, and technical textiles, and has established a strategic partnership with Gruschwitz Textilwerke AG. The company employs a patented biotechnological process to create biodegradable polymers from silk proteins, enabling the production of various forms such as powders, hydrogels, and fibers that are environmentally friendly.

talpasolutions a predictive SaaS analytics provider for the mining industry that helps companies optimize machine performance, reduce breakdowns, and improve safety by making data more understandable. talpasolutions makes it possible for operators and machine manufacturers in heavy industry to use machine data that would have otherwise been lost. talpasolutions concentrates on building visualization and analysis applications for the industrial internet. In the first step, large amounts of data from the machines are recorded. Comprehendable visualizations allow for different stakeholders to understand relationships based on sensor data and contextual data and to react to critical information, which would otherwise have been buried in the data transfer. In the second step the newest predictive models are applied to eliminate events such as errors and the breakdown of machines critical to the process. This increases not only the availability but also the workload of the machines. talpasolutions has built a network out of industry partners to develop solutions that stretch across various sectors and unify industry experience, data science, and workflow connectivity. Using predictive instructions our platform recognizes problems before they occur and supports users with workflow-based processes. Our applications make it possible to collect performance data from machines in order to recommend optimal fleet combinations for respective scenarios to customers. This leads to more operating hours, higher efficiency, and an improved lifetime value of the machines.

Mbiomics is a biotechnology company focused on microbiome research, diagnostics, and therapeutics. It has developed a high-throughput, low-cost platform that allows for dynamic and real-time analysis and quantification of the human gut microbiome. By providing informed precision diagnostics and targeted therapies, Mbiomics aims to enhance patient outcomes and promote healthier living through innovative approaches.

KEWAZO GmbH, founded in 2016 and based in Gilching, Germany, specializes in developing robotic systems for the construction industry, specifically aimed at enhancing material transport for scaffolding companies and industrial service providers. The company's flagship product, the robotic material hoist LIFTBOT, automates the flow of materials both vertically and horizontally on construction sites, significantly reducing labor costs and addressing labor shortages while improving safety. By integrating these robotic platforms on-site, KEWAZO not only facilitates just-in-time and just-in-place delivery of scaffolding parts during assembly but also collects operational data. This data is made available to clients through a comprehensive analytics platform, enabling more proactive management of projects and overall company operations.

Inbolt specializes in developing advanced vision systems for industrial robots, aimed at enhancing decision-making capabilities in various environments. By utilizing artificial intelligence and 3D vision, Inbolt's technology provides adaptive real-time guidance for robots, allowing them to operate more intelligently. Additionally, the company's vision-based tools facilitate the automation of complex tasks in unstructured settings, offering real-time quality control for manual operations like torquing, drilling, and riveting. This innovation not only reduces the incidence of faulty operations but also significantly improves overall quality control in industrial processes.

NavVis is a technology company based in Munich, Germany, specializing in indoor spatial intelligence and digital twin solutions. The company offers mobile mapping systems that utilize simultaneous localization and mapping (SLAM) technology to generate high-quality, survey-grade data quickly and efficiently. Its platform is designed to assist service providers and enterprises in capturing and sharing the built environment as photorealistic digital twins, enabling better operational decisions and increased productivity. NavVis's digital factory solutions facilitate improved business processes and profitability for clients in industries such as surveying, architecture, engineering, construction, and manufacturing. With additional offices in the United States and China, NavVis serves a global customer base, providing tools for accurate 3D mapping and immersive visualization of industrial facilities.

Founded in 2017, GoBolt is a technology company building the first sustainable and vertically integrated supply chain network that partners with merchants to deliver a complete end-to-end customer experience. By operating as an extension of each merchant’s team, GoBolt provides reliable warehousing, pick and pack, shipping, and last mile delivery. With a growing network of warehouses across North America and a suite of proprietary apps designed and supported by an in-house engineering team, GoBolt unlocks enhanced transparency and control for merchants. The company’s focus on customer-centricity is further driven by a deep commitment to sustainability. GoBolt’s investment in its electric vehicle fleet and sustainability partnerships is a testament to the company’s mission to provide carbon neutral deliveries. For more information, visit GoBolt.com.

Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is known for its innovative eChiller, which utilizes pure water as a refrigerant, effectively eliminating the need for harmful fluorinated refrigerants. This clean compression refrigeration unit is designed for various cooling needs, including data centers, server rooms, and industrial processes, with cooling capacities ranging from 35 kW to 120 kW. In addition to its products, Efficient Energy offers a range of services, including consulting, planning, installation, and energy efficiency optimization. The company's pioneering technology has garnered recognition, receiving several awards, including the European Business Award for the Environment and recognition in the Deloitte Technology Fast 50. Efficient Energy aims to provide sustainable, efficient, and cost-effective cooling solutions to meet the growing regulatory challenges in the refrigeration industry.

iOmx Therapeutics AG is a Munich-based company specializing in immuno-oncology target discovery and drug development. The firm focuses on creating innovative cancer therapeutics that target novel immune checkpoint modulators present on tumor cells. By employing a systematic screening approach of human tumor cells, iOmx Therapeutics has identified several new targets and examined their mechanisms of action. The company's foundation is built upon the principles of cancer immune-checkpoint therapy, which aims to overcome the resistance mechanisms that tumors utilize to evade immune attacks. These resistance mechanisms often involve specific cell surface molecules that activate immune-inhibitory receptors on T cells. By neutralizing these negative interactions, iOmx Therapeutics seeks to reactivate the host immune response, ultimately enhancing the effectiveness of cancer treatments.

KEWAZO GmbH, founded in 2016 and based in Gilching, Germany, specializes in developing robotic systems for the construction industry, specifically aimed at enhancing material transport for scaffolding companies and industrial service providers. The company's flagship product, the robotic material hoist LIFTBOT, automates the flow of materials both vertically and horizontally on construction sites, significantly reducing labor costs and addressing labor shortages while improving safety. By integrating these robotic platforms on-site, KEWAZO not only facilitates just-in-time and just-in-place delivery of scaffolding parts during assembly but also collects operational data. This data is made available to clients through a comprehensive analytics platform, enabling more proactive management of projects and overall company operations.

AMSilk GmbH, founded in 2008 and based in Munich, Germany, specializes in producing spider silk proteins and other biomaterials for various industrial applications. The company offers a range of products, including BioShield-S1, a non-immunogenic spider silk film for protective coatings, and biosteel spider silk fibers. Additionally, AMSilk provides wound care products such as SanaSilk, designed to protect the skin, and spider silk-based solutions for surgical applications. Their product portfolio also includes spider silk protein beads and coatings for medical technology, as well as nonwovens for use in filters, wound dressings, and specialty textiles. AMSilk serves multiple sectors, including pharmaceuticals, cosmetics, and technical textiles, and has established a strategic partnership with Gruschwitz Textilwerke AG. The company employs a patented biotechnological process to create biodegradable polymers from silk proteins, enabling the production of various forms such as powders, hydrogels, and fibers that are environmentally friendly.

Founded in 2017, GoBolt is a technology company building the first sustainable and vertically integrated supply chain network that partners with merchants to deliver a complete end-to-end customer experience. By operating as an extension of each merchant’s team, GoBolt provides reliable warehousing, pick and pack, shipping, and last mile delivery. With a growing network of warehouses across North America and a suite of proprietary apps designed and supported by an in-house engineering team, GoBolt unlocks enhanced transparency and control for merchants. The company’s focus on customer-centricity is further driven by a deep commitment to sustainability. GoBolt’s investment in its electric vehicle fleet and sustainability partnerships is a testament to the company’s mission to provide carbon neutral deliveries. For more information, visit GoBolt.com.

Liva Healthcare is a digital health coaching platform focused on scalable lifestyle and disease management, particularly for chronic conditions such as Type 2 diabetes, obesity, and heart disease. The company provides an intuitive app that fosters personalized health coaching, creating strong connections between coaches, general practitioners, and patients. Its platform is designed to engage patients over nine to 18 months, promoting sustainable behavior change and habit formation. Liva Healthcare's services are utilized by various organizations, including public healthcare systems and private insurers. The app is multilingual and effective across diverse socio-economic groups, allowing one coach to manage up to 500 patients simultaneously. Implementation typically occurs within weeks, and the platform is offered as both a white-label Software as a Service solution and a turn-key option, tailored to client needs. Liva Healthcare operates from offices in Copenhagen, Denmark, and London, UK.

German Bionic is a manufacturer of innovative exoskeletons designed to enhance efficiency and productivity in industrial settings. The company has developed the Cray X, the world's first connected exoskeleton, which integrates with Smart Factory systems to self-learn and reinforce proper lifting techniques, thereby preventing incorrect posture. This technology serves as an intelligent interface between humans and machines, providing valuable data that demonstrates its effectiveness in protecting workers' health and significantly reducing the risk of accidents and strain-related injuries. Supported by prominent investors such as Samsung Catalyst Fund and Storm Ventures, German Bionic has received numerous accolades, including the German Entrepreneur Award and the Automatica Award, highlighting its impact on improving workplace safety and operational processes.

Innatera is an innovative developer of ultra-low power neuromorphic processors designed to enhance the efficiency of sensor data processing. Established in 2018 as a spin-off from the Delft University of Technology, the company focuses on creating processors that replicate the brain's mechanisms for sensory perception. Utilizing a novel continuous-time analog-mixed signal processing architecture, Innatera's chips can process sensor data up to 100 times faster while consuming up to 500 times less energy compared to traditional processors. This technology enables businesses to access and analyze sensor data more effectively, positioning Innatera as a leader in the field of energy-efficient computing solutions.

Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is known for its innovative eChiller, which utilizes pure water as a refrigerant, effectively eliminating the need for harmful fluorinated refrigerants. This clean compression refrigeration unit is designed for various cooling needs, including data centers, server rooms, and industrial processes, with cooling capacities ranging from 35 kW to 120 kW. In addition to its products, Efficient Energy offers a range of services, including consulting, planning, installation, and energy efficiency optimization. The company's pioneering technology has garnered recognition, receiving several awards, including the European Business Award for the Environment and recognition in the Deloitte Technology Fast 50. Efficient Energy aims to provide sustainable, efficient, and cost-effective cooling solutions to meet the growing regulatory challenges in the refrigeration industry.

KEWAZO GmbH, founded in 2016 and based in Gilching, Germany, specializes in developing robotic systems for the construction industry, specifically aimed at enhancing material transport for scaffolding companies and industrial service providers. The company's flagship product, the robotic material hoist LIFTBOT, automates the flow of materials both vertically and horizontally on construction sites, significantly reducing labor costs and addressing labor shortages while improving safety. By integrating these robotic platforms on-site, KEWAZO not only facilitates just-in-time and just-in-place delivery of scaffolding parts during assembly but also collects operational data. This data is made available to clients through a comprehensive analytics platform, enabling more proactive management of projects and overall company operations.

Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.

IQM Quantum Computers, founded in 2018 and headquartered in Espoo, Finland, specializes in developing and manufacturing hardware systems for quantum computing. The company focuses on scalable hardware solutions utilizing superconducting technology to build quantum processors for universal quantum computers. By concentrating on practical applications, IQM aims to enhance quantum computing capabilities and address challenges faced by various industries and society. As a spin-out from Aalto University and the VTT Technical Research Centre of Finland, IQM has achieved significant advancements in areas such as thermal management, which are crucial for improving computational speed and information accuracy. The company's innovations position it as a leader in the global pursuit of large-scale quantum computing solutions. IQM also offers access to its hardware for research laboratories and supercomputing centers, helping businesses reduce error rates that currently limit computing performance.

CYNORA GmbH, founded in 2008 and headquartered in Bruchsal, Germany, specializes in the development and manufacture of organic electronics, particularly organic light-emitting diodes (OLEDs). The company focuses on creating highly efficient blue and green emitter systems utilizing Thermally Activated Delayed Fluorescence (TADF) technology. This innovative approach allows for the conversion of triplet excitons into light, thereby enhancing power efficiency and reducing electrical stress within OLED devices. As demand for thin, flexible screens with improved image quality and lower power consumption rises, CYNORA aims to provide added value to OLED producers with its iridium-free, purely organic emitter solutions. By addressing the challenges faced in developing stable and efficient blue emitters, CYNORA is positioned to support advancements in the AMOLED market and contribute to the evolution of display technology.

Liva Healthcare is a digital health coaching platform focused on scalable lifestyle and disease management, particularly for chronic conditions such as Type 2 diabetes, obesity, and heart disease. The company provides an intuitive app that fosters personalized health coaching, creating strong connections between coaches, general practitioners, and patients. Its platform is designed to engage patients over nine to 18 months, promoting sustainable behavior change and habit formation. Liva Healthcare's services are utilized by various organizations, including public healthcare systems and private insurers. The app is multilingual and effective across diverse socio-economic groups, allowing one coach to manage up to 500 patients simultaneously. Implementation typically occurs within weeks, and the platform is offered as both a white-label Software as a Service solution and a turn-key option, tailored to client needs. Liva Healthcare operates from offices in Copenhagen, Denmark, and London, UK.

Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is known for its innovative eChiller, which utilizes pure water as a refrigerant, effectively eliminating the need for harmful fluorinated refrigerants. This clean compression refrigeration unit is designed for various cooling needs, including data centers, server rooms, and industrial processes, with cooling capacities ranging from 35 kW to 120 kW. In addition to its products, Efficient Energy offers a range of services, including consulting, planning, installation, and energy efficiency optimization. The company's pioneering technology has garnered recognition, receiving several awards, including the European Business Award for the Environment and recognition in the Deloitte Technology Fast 50. Efficient Energy aims to provide sustainable, efficient, and cost-effective cooling solutions to meet the growing regulatory challenges in the refrigeration industry.

KONUX GmbH, founded in 2014 and based in Munich, Germany, specializes in the development of Industrial Internet of Things (IIoT) solutions that integrate smart sensor systems with artificial intelligence-based analytics. The company's offerings include switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and predictive analytics, all aimed at enhancing railway and industrial operations. By providing real-time monitoring and predictive maintenance capabilities, KONUX helps clients improve the reliability, capacity, and cost-efficiency of their railway systems. The company has expanded its reach across multiple countries in Europe and Asia and has been recognized by the World Economic Forum as one of the world's most innovative start-ups. With over $130 million raised from leading investors, KONUX is committed to modernizing railroad operations and contributing to a sustainable future in mobility.

NavVis is a technology company based in Munich, Germany, specializing in indoor spatial intelligence and digital twin solutions. The company offers mobile mapping systems that utilize simultaneous localization and mapping (SLAM) technology to generate high-quality, survey-grade data quickly and efficiently. Its platform is designed to assist service providers and enterprises in capturing and sharing the built environment as photorealistic digital twins, enabling better operational decisions and increased productivity. NavVis's digital factory solutions facilitate improved business processes and profitability for clients in industries such as surveying, architecture, engineering, construction, and manufacturing. With additional offices in the United States and China, NavVis serves a global customer base, providing tools for accurate 3D mapping and immersive visualization of industrial facilities.

GWA Hygiene GmbH is a German company based in Stralsund, founded in 2015, specializing in hygiene monitoring systems for healthcare settings. The company designs and manufactures sensors that monitor hand hygiene standards among hospital personnel, as well as developing a software application that tracks disinfection rates across various wards and professional groups. GWA Hygiene's solutions integrate the Internet of Things (IoT) technology, allowing for the monitoring of both hand and surface disinfection processes. Their sensor technology is installed in disinfectant and soap dispensers, providing real-time data displayed on monitors. Users can choose to store data on an in-house server or utilize the company’s secure cloud server. The accompanying software toolbox enables analysis of hygiene processes and streamlines logistical tasks, such as managing disinfectant supplies and maintaining devices.

Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is known for its innovative eChiller, which utilizes pure water as a refrigerant, effectively eliminating the need for harmful fluorinated refrigerants. This clean compression refrigeration unit is designed for various cooling needs, including data centers, server rooms, and industrial processes, with cooling capacities ranging from 35 kW to 120 kW. In addition to its products, Efficient Energy offers a range of services, including consulting, planning, installation, and energy efficiency optimization. The company's pioneering technology has garnered recognition, receiving several awards, including the European Business Award for the Environment and recognition in the Deloitte Technology Fast 50. Efficient Energy aims to provide sustainable, efficient, and cost-effective cooling solutions to meet the growing regulatory challenges in the refrigeration industry.

advanceCOR GmbH is a drug development company based in Munich, Germany, specializing in therapeutics and diagnostics for heart and vascular diseases. Founded in 2000, the company focuses on creating personalized treatments and has developed several innovative products. Notable among these is Revacept, a human Fc fusion protein that inhibits the local activation of platelets at vascular injury sites. Additionally, advanceCOR offers COR-2, a recombinant protein that reduces foam cell generation and cholesterol uptake, and COR-3, which targets atherosclerotic plaques while binding to progenitor cells to promote plaque healing. The company’s product pipeline also includes therapies for acute arterial thrombosis, myocardial infarction, stroke, and transient ischemic attack, emphasizing its commitment to addressing serious cardiovascular conditions.

KEWAZO GmbH, founded in 2016 and based in Gilching, Germany, specializes in developing robotic systems for the construction industry, specifically aimed at enhancing material transport for scaffolding companies and industrial service providers. The company's flagship product, the robotic material hoist LIFTBOT, automates the flow of materials both vertically and horizontally on construction sites, significantly reducing labor costs and addressing labor shortages while improving safety. By integrating these robotic platforms on-site, KEWAZO not only facilitates just-in-time and just-in-place delivery of scaffolding parts during assembly but also collects operational data. This data is made available to clients through a comprehensive analytics platform, enabling more proactive management of projects and overall company operations.

KONUX GmbH, founded in 2014 and based in Munich, Germany, specializes in the development of Industrial Internet of Things (IIoT) solutions that integrate smart sensor systems with artificial intelligence-based analytics. The company's offerings include switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and predictive analytics, all aimed at enhancing railway and industrial operations. By providing real-time monitoring and predictive maintenance capabilities, KONUX helps clients improve the reliability, capacity, and cost-efficiency of their railway systems. The company has expanded its reach across multiple countries in Europe and Asia and has been recognized by the World Economic Forum as one of the world's most innovative start-ups. With over $130 million raised from leading investors, KONUX is committed to modernizing railroad operations and contributing to a sustainable future in mobility.

BioNTech is a Germany-based biotechnology company that specializes in developing innovative immunotherapies for cancer and other serious diseases, as well as vaccines for infectious diseases, including COVID-19. The company’s oncology pipeline includes a range of drug classes, such as mRNA-based drugs that encode antigens and neoantigens, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech has established partnerships with several major pharmaceutical companies, enhancing its research and development capabilities. Its COVID-19 vaccine, Comirnaty, represents its first commercialized product, demonstrating the company's commitment to addressing urgent health challenges through advanced therapeutic approaches.

Siltectra GmbH, based in Dresden, Germany, specializes in advanced laser-based wafering technology solutions for semiconductor manufacturers. Founded in 2010, the company focuses on kerfless wafering, a method that allows for the separation of wafers from semiconductor materials like silicon carbide, gallium nitride, and sapphire without material loss. This innovative technology can be applied across various industries, particularly in solar inverters and other electronic devices, offering significant performance and cost advantages. Siltectra operates as a subsidiary of Infineon Technologies AG, providing critical services that enhance the efficiency of the global semiconductor industry.

Hemovent, based in Aachen, Germany, is a privately held medical technology company focused on developing a portable ECMO (Extracorporeal Membrane Oxygenation) unit. Founded by Christof Lenz and Oliver Marseille, the company aims to create an innovative device that supports or replaces heart and lung functions in cases of cardiac or respiratory failure. Hemovent's portable unit provides critical respiratory support for patients whose lungs are severely compromised, acting as a temporary life support system that takes over heart function during acute heart failure. This technology allows hospitals to stabilize patients and address the underlying issues leading to the failure while enabling patient mobility, thereby enhancing treatment options and outcomes.

Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is known for its innovative eChiller, which utilizes pure water as a refrigerant, effectively eliminating the need for harmful fluorinated refrigerants. This clean compression refrigeration unit is designed for various cooling needs, including data centers, server rooms, and industrial processes, with cooling capacities ranging from 35 kW to 120 kW. In addition to its products, Efficient Energy offers a range of services, including consulting, planning, installation, and energy efficiency optimization. The company's pioneering technology has garnered recognition, receiving several awards, including the European Business Award for the Environment and recognition in the Deloitte Technology Fast 50. Efficient Energy aims to provide sustainable, efficient, and cost-effective cooling solutions to meet the growing regulatory challenges in the refrigeration industry.

AFFiRiS AG is a Vienna-based company specializing in the development and manufacture of peptide-based vaccines aimed at treating chronic diseases that have significant unmet medical needs. Established in 2003, the company's portfolio includes vaccines targeting a range of conditions such as Alzheimer’s disease, Parkinson’s disease, atherosclerosis, hypertension, diabetes, psoriasis, allergies, asthma, and Huntington’s disease, among others. By focusing on tailored therapeutic solutions, AFFiRiS aims to address critical health challenges through innovative vaccine technology.

LXP Group GmbH, founded in 2009 and based in Marienwerder, Germany, specializes in the development of the LX-Process, a technology that effectively cracks second-generation (2G) biomass. This innovative process enables the production of 2G ethanol, bio-based chemicals, and natural lignin, addressing challenges in bio-processing, particularly the inhibition issues found in existing pre-treatment methods. The LX-Process is versatile, suitable for large-scale ethanol manufacturing while also being adaptable for retrofitting smaller, decentralized biogas plants. By utilizing agricultural residues, LXP Group contributes to the sustainable production of renewable energy and bio-based products. Formerly known as MaxBiogas GmbH, the company continues to advance its technology to enhance the efficiency and economic viability of biomass conversion.

Siltectra GmbH, based in Dresden, Germany, specializes in advanced laser-based wafering technology solutions for semiconductor manufacturers. Founded in 2010, the company focuses on kerfless wafering, a method that allows for the separation of wafers from semiconductor materials like silicon carbide, gallium nitride, and sapphire without material loss. This innovative technology can be applied across various industries, particularly in solar inverters and other electronic devices, offering significant performance and cost advantages. Siltectra operates as a subsidiary of Infineon Technologies AG, providing critical services that enhance the efficiency of the global semiconductor industry.

KONUX GmbH, founded in 2014 and based in Munich, Germany, specializes in the development of Industrial Internet of Things (IIoT) solutions that integrate smart sensor systems with artificial intelligence-based analytics. The company's offerings include switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and predictive analytics, all aimed at enhancing railway and industrial operations. By providing real-time monitoring and predictive maintenance capabilities, KONUX helps clients improve the reliability, capacity, and cost-efficiency of their railway systems. The company has expanded its reach across multiple countries in Europe and Asia and has been recognized by the World Economic Forum as one of the world's most innovative start-ups. With over $130 million raised from leading investors, KONUX is committed to modernizing railroad operations and contributing to a sustainable future in mobility.

AFFiRiS AG is a Vienna-based company specializing in the development and manufacture of peptide-based vaccines aimed at treating chronic diseases that have significant unmet medical needs. Established in 2003, the company's portfolio includes vaccines targeting a range of conditions such as Alzheimer’s disease, Parkinson’s disease, atherosclerosis, hypertension, diabetes, psoriasis, allergies, asthma, and Huntington’s disease, among others. By focusing on tailored therapeutic solutions, AFFiRiS aims to address critical health challenges through innovative vaccine technology.

Siltectra GmbH, based in Dresden, Germany, specializes in advanced laser-based wafering technology solutions for semiconductor manufacturers. Founded in 2010, the company focuses on kerfless wafering, a method that allows for the separation of wafers from semiconductor materials like silicon carbide, gallium nitride, and sapphire without material loss. This innovative technology can be applied across various industries, particularly in solar inverters and other electronic devices, offering significant performance and cost advantages. Siltectra operates as a subsidiary of Infineon Technologies AG, providing critical services that enhance the efficiency of the global semiconductor industry.

KONUX GmbH, founded in 2014 and based in Munich, Germany, specializes in the development of Industrial Internet of Things (IIoT) solutions that integrate smart sensor systems with artificial intelligence-based analytics. The company's offerings include switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and predictive analytics, all aimed at enhancing railway and industrial operations. By providing real-time monitoring and predictive maintenance capabilities, KONUX helps clients improve the reliability, capacity, and cost-efficiency of their railway systems. The company has expanded its reach across multiple countries in Europe and Asia and has been recognized by the World Economic Forum as one of the world's most innovative start-ups. With over $130 million raised from leading investors, KONUX is committed to modernizing railroad operations and contributing to a sustainable future in mobility.

Hemovent, based in Aachen, Germany, is a privately held medical technology company focused on developing a portable ECMO (Extracorporeal Membrane Oxygenation) unit. Founded by Christof Lenz and Oliver Marseille, the company aims to create an innovative device that supports or replaces heart and lung functions in cases of cardiac or respiratory failure. Hemovent's portable unit provides critical respiratory support for patients whose lungs are severely compromised, acting as a temporary life support system that takes over heart function during acute heart failure. This technology allows hospitals to stabilize patients and address the underlying issues leading to the failure while enabling patient mobility, thereby enhancing treatment options and outcomes.

NavVis is a technology company based in Munich, Germany, specializing in indoor spatial intelligence and digital twin solutions. The company offers mobile mapping systems that utilize simultaneous localization and mapping (SLAM) technology to generate high-quality, survey-grade data quickly and efficiently. Its platform is designed to assist service providers and enterprises in capturing and sharing the built environment as photorealistic digital twins, enabling better operational decisions and increased productivity. NavVis's digital factory solutions facilitate improved business processes and profitability for clients in industries such as surveying, architecture, engineering, construction, and manufacturing. With additional offices in the United States and China, NavVis serves a global customer base, providing tools for accurate 3D mapping and immersive visualization of industrial facilities.

Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is known for its innovative eChiller, which utilizes pure water as a refrigerant, effectively eliminating the need for harmful fluorinated refrigerants. This clean compression refrigeration unit is designed for various cooling needs, including data centers, server rooms, and industrial processes, with cooling capacities ranging from 35 kW to 120 kW. In addition to its products, Efficient Energy offers a range of services, including consulting, planning, installation, and energy efficiency optimization. The company's pioneering technology has garnered recognition, receiving several awards, including the European Business Award for the Environment and recognition in the Deloitte Technology Fast 50. Efficient Energy aims to provide sustainable, efficient, and cost-effective cooling solutions to meet the growing regulatory challenges in the refrigeration industry.

Siltectra GmbH, based in Dresden, Germany, specializes in advanced laser-based wafering technology solutions for semiconductor manufacturers. Founded in 2010, the company focuses on kerfless wafering, a method that allows for the separation of wafers from semiconductor materials like silicon carbide, gallium nitride, and sapphire without material loss. This innovative technology can be applied across various industries, particularly in solar inverters and other electronic devices, offering significant performance and cost advantages. Siltectra operates as a subsidiary of Infineon Technologies AG, providing critical services that enhance the efficiency of the global semiconductor industry.

Protagen is a precision medicine company that specializes in drug development and patient management, particularly in the fields of autoimmune diseases and immuno-oncology. The company focuses on immuno-profiling and the discovery of novel autoantibody signatures, utilizing its SeroTag® technology to identify biomarkers that address challenges in the development of cancer immunotherapies and treatments for autoimmune conditions. Protagen is recognized for its expertise in patient stratification, having created disease-specific NavigAID panels that assess individual patients' autoimmune conditions and immune statuses. This tailored approach enables the development of more targeted therapies for various autoimmune diseases, including systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjögren’s syndrome. Additionally, Protagen's biomarker discovery platform aids in the detection of autoantibodies in patients undergoing cancer immunotherapy, which helps predict treatment responses and supports informed therapeutic decisions.

NavVis is a technology company based in Munich, Germany, specializing in indoor spatial intelligence and digital twin solutions. The company offers mobile mapping systems that utilize simultaneous localization and mapping (SLAM) technology to generate high-quality, survey-grade data quickly and efficiently. Its platform is designed to assist service providers and enterprises in capturing and sharing the built environment as photorealistic digital twins, enabling better operational decisions and increased productivity. NavVis's digital factory solutions facilitate improved business processes and profitability for clients in industries such as surveying, architecture, engineering, construction, and manufacturing. With additional offices in the United States and China, NavVis serves a global customer base, providing tools for accurate 3D mapping and immersive visualization of industrial facilities.

Siltectra GmbH, based in Dresden, Germany, specializes in advanced laser-based wafering technology solutions for semiconductor manufacturers. Founded in 2010, the company focuses on kerfless wafering, a method that allows for the separation of wafers from semiconductor materials like silicon carbide, gallium nitride, and sapphire without material loss. This innovative technology can be applied across various industries, particularly in solar inverters and other electronic devices, offering significant performance and cost advantages. Siltectra operates as a subsidiary of Infineon Technologies AG, providing critical services that enhance the efficiency of the global semiconductor industry.

Isarna Therapeutics is focused on developing selective TGF-β inhibitors aimed at treating ophthalmic diseases, fibrotic conditions, and cancer. The company is advancing a unique pipeline that includes novel oligonucleotides and combination therapies designed to enhance clinical responses and improve patient outcomes. Through its innovative approach, Isarna Therapeutics seeks to address significant unmet medical needs in these areas.

Isarna Therapeutics is focused on developing selective TGF-β inhibitors aimed at treating ophthalmic diseases, fibrotic conditions, and cancer. The company is advancing a unique pipeline that includes novel oligonucleotides and combination therapies designed to enhance clinical responses and improve patient outcomes. Through its innovative approach, Isarna Therapeutics seeks to address significant unmet medical needs in these areas.

Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

SuppreMol is a private biotechnology company that specializes in developing therapeutics for autoimmune and allergic diseases. The company is dedicated to creating innovative treatments aimed at addressing the underlying causes of these disorders, rather than just alleviating their symptoms. SuppreMol's research focuses on soluble Fc-gamma receptors, which are recombinant autologous therapeutic proteins designed to possess specific immunoregulatory properties. This approach has the potential to advance the treatment landscape for individuals suffering from autoimmune conditions, offering new hope for more effective and long-lasting solutions.

Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is known for its innovative eChiller, which utilizes pure water as a refrigerant, effectively eliminating the need for harmful fluorinated refrigerants. This clean compression refrigeration unit is designed for various cooling needs, including data centers, server rooms, and industrial processes, with cooling capacities ranging from 35 kW to 120 kW. In addition to its products, Efficient Energy offers a range of services, including consulting, planning, installation, and energy efficiency optimization. The company's pioneering technology has garnered recognition, receiving several awards, including the European Business Award for the Environment and recognition in the Deloitte Technology Fast 50. Efficient Energy aims to provide sustainable, efficient, and cost-effective cooling solutions to meet the growing regulatory challenges in the refrigeration industry.

Siltectra GmbH, based in Dresden, Germany, specializes in advanced laser-based wafering technology solutions for semiconductor manufacturers. Founded in 2010, the company focuses on kerfless wafering, a method that allows for the separation of wafers from semiconductor materials like silicon carbide, gallium nitride, and sapphire without material loss. This innovative technology can be applied across various industries, particularly in solar inverters and other electronic devices, offering significant performance and cost advantages. Siltectra operates as a subsidiary of Infineon Technologies AG, providing critical services that enhance the efficiency of the global semiconductor industry.

SuppreMol is a private biotechnology company that specializes in developing therapeutics for autoimmune and allergic diseases. The company is dedicated to creating innovative treatments aimed at addressing the underlying causes of these disorders, rather than just alleviating their symptoms. SuppreMol's research focuses on soluble Fc-gamma receptors, which are recombinant autologous therapeutic proteins designed to possess specific immunoregulatory properties. This approach has the potential to advance the treatment landscape for individuals suffering from autoimmune conditions, offering new hope for more effective and long-lasting solutions.

Siltectra GmbH, based in Dresden, Germany, specializes in advanced laser-based wafering technology solutions for semiconductor manufacturers. Founded in 2010, the company focuses on kerfless wafering, a method that allows for the separation of wafers from semiconductor materials like silicon carbide, gallium nitride, and sapphire without material loss. This innovative technology can be applied across various industries, particularly in solar inverters and other electronic devices, offering significant performance and cost advantages. Siltectra operates as a subsidiary of Infineon Technologies AG, providing critical services that enhance the efficiency of the global semiconductor industry.

NFON is a Munich-based provider of cloud-based telecommunications services, specializing in integrated business communication solutions for corporate customers across Europe. The company's primary offering is its outsourced telephone system, known as IP Centrex, which delivers a comprehensive package designed to help businesses of all sizes reduce phone system costs by up to 50%. NFON's services encompass various aspects of business communication, including telephony, video calls, and screen sharing, along with necessary hardware components. The company also focuses on integration, ensuring that its cloud telephony system seamlessly fits into existing customer workflows and business processes. Additionally, NFON offers products aimed at optimizing customer contact, as well as services that prepare companies for cloud transition, enhancing their operational efficiency. With a fully redundant, high-performance computer center and over 100 functions, NFON is positioned as a key player in the telecommunications sector.

AFFiRiS AG is a Vienna-based company specializing in the development and manufacture of peptide-based vaccines aimed at treating chronic diseases that have significant unmet medical needs. Established in 2003, the company's portfolio includes vaccines targeting a range of conditions such as Alzheimer’s disease, Parkinson’s disease, atherosclerosis, hypertension, diabetes, psoriasis, allergies, asthma, and Huntington’s disease, among others. By focusing on tailored therapeutic solutions, AFFiRiS aims to address critical health challenges through innovative vaccine technology.

IDENT Technology AG specializes in technology solutions for near-field communication and gesture-controlled human-machine interfaces. Based in Wessling, Germany, the company offers a range of products under its SKINPLEX brand, including SKINPLEX GestIC for gesture detection, a zeropower sensor system for touchless applications, and an ultra-low-power proximity system designed to manage device power based on user proximity. These technologies are particularly relevant for various industries, including consumer electronics, gaming, healthcare, telecommunications, and automotive. Founded in 2002, IDENT Technology focuses on providing innovative solutions that enhance user interaction through advanced sensing and identification capabilities.

Isarna Therapeutics is focused on developing selective TGF-β inhibitors aimed at treating ophthalmic diseases, fibrotic conditions, and cancer. The company is advancing a unique pipeline that includes novel oligonucleotides and combination therapies designed to enhance clinical responses and improve patient outcomes. Through its innovative approach, Isarna Therapeutics seeks to address significant unmet medical needs in these areas.

CYNORA GmbH, founded in 2008 and headquartered in Bruchsal, Germany, specializes in the development and manufacture of organic electronics, particularly organic light-emitting diodes (OLEDs). The company focuses on creating highly efficient blue and green emitter systems utilizing Thermally Activated Delayed Fluorescence (TADF) technology. This innovative approach allows for the conversion of triplet excitons into light, thereby enhancing power efficiency and reducing electrical stress within OLED devices. As demand for thin, flexible screens with improved image quality and lower power consumption rises, CYNORA aims to provide added value to OLED producers with its iridium-free, purely organic emitter solutions. By addressing the challenges faced in developing stable and efficient blue emitters, CYNORA is positioned to support advancements in the AMOLED market and contribute to the evolution of display technology.

AMSilk GmbH, founded in 2008 and based in Munich, Germany, specializes in producing spider silk proteins and other biomaterials for various industrial applications. The company offers a range of products, including BioShield-S1, a non-immunogenic spider silk film for protective coatings, and biosteel spider silk fibers. Additionally, AMSilk provides wound care products such as SanaSilk, designed to protect the skin, and spider silk-based solutions for surgical applications. Their product portfolio also includes spider silk protein beads and coatings for medical technology, as well as nonwovens for use in filters, wound dressings, and specialty textiles. AMSilk serves multiple sectors, including pharmaceuticals, cosmetics, and technical textiles, and has established a strategic partnership with Gruschwitz Textilwerke AG. The company employs a patented biotechnological process to create biodegradable polymers from silk proteins, enabling the production of various forms such as powders, hydrogels, and fibers that are environmentally friendly.

Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is known for its innovative eChiller, which utilizes pure water as a refrigerant, effectively eliminating the need for harmful fluorinated refrigerants. This clean compression refrigeration unit is designed for various cooling needs, including data centers, server rooms, and industrial processes, with cooling capacities ranging from 35 kW to 120 kW. In addition to its products, Efficient Energy offers a range of services, including consulting, planning, installation, and energy efficiency optimization. The company's pioneering technology has garnered recognition, receiving several awards, including the European Business Award for the Environment and recognition in the Deloitte Technology Fast 50. Efficient Energy aims to provide sustainable, efficient, and cost-effective cooling solutions to meet the growing regulatory challenges in the refrigeration industry.

SuppreMol is a private biotechnology company that specializes in developing therapeutics for autoimmune and allergic diseases. The company is dedicated to creating innovative treatments aimed at addressing the underlying causes of these disorders, rather than just alleviating their symptoms. SuppreMol's research focuses on soluble Fc-gamma receptors, which are recombinant autologous therapeutic proteins designed to possess specific immunoregulatory properties. This approach has the potential to advance the treatment landscape for individuals suffering from autoimmune conditions, offering new hope for more effective and long-lasting solutions.

Corimmun is a clinical drug development company based in Martinsried, near Munich, Germany. The company specializes in creating innovative therapeutics and diagnostics aimed at treating heart and vascular diseases, particularly those that currently have unmet medical needs. Corimmun's expertise encompasses the entire spectrum of drug development, from initial research through to commercialization, positioning it as a key player in the field of cardiovascular therapeutics.

immatics is a biopharmaceutical company focused on the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's customized Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics are the two main product classes in the pipeline (TCER). With a focus on particularly difficult-to-treat solid malignancies, each therapy modality has unique characteristics to create the desired therapeutic impact for patients at various disease stages and with various types of tumors. immatics biotechnologies was established in 2000 by Hans Rammensee, Harpreet Singh, and Steffen Walter in Tübingen, Baden-Wurttemberg.

IDENT Technology AG specializes in technology solutions for near-field communication and gesture-controlled human-machine interfaces. Based in Wessling, Germany, the company offers a range of products under its SKINPLEX brand, including SKINPLEX GestIC for gesture detection, a zeropower sensor system for touchless applications, and an ultra-low-power proximity system designed to manage device power based on user proximity. These technologies are particularly relevant for various industries, including consumer electronics, gaming, healthcare, telecommunications, and automotive. Founded in 2002, IDENT Technology focuses on providing innovative solutions that enhance user interaction through advanced sensing and identification capabilities.

Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.

Isarna Therapeutics is focused on developing selective TGF-β inhibitors aimed at treating ophthalmic diseases, fibrotic conditions, and cancer. The company is advancing a unique pipeline that includes novel oligonucleotides and combination therapies designed to enhance clinical responses and improve patient outcomes. Through its innovative approach, Isarna Therapeutics seeks to address significant unmet medical needs in these areas.

PDC Biotech GmbH is a biotechnology company based in Vienna, Austria, specializing in the development of innovative therapeutics for the treatment of preterm labor and primary dysmenorrhea, both of which represent significant unmet medical needs. Established in 2008, PDC Biotech focuses on creating a pipeline of products that act as antagonists of the prostaglandin F2α (FP) receptor. Its key products include PDC31, a synthetic octapeptide designed as an allosteric modulator of the FP receptor, and the PDC41 Series, which offers a non-intravenous formulation for self-administration in primary dysmenorrhea. The company employs various delivery methods for its formulations, including nasal, sublingual, pulmonary, vaginal, and rectal suppositories. PDC Biotech has secured exclusive worldwide rights to a family of FP receptor antagonists from Theratechnologies Inc., further enhancing its position in the biopharmaceutical landscape.

Protagen is a precision medicine company that specializes in drug development and patient management, particularly in the fields of autoimmune diseases and immuno-oncology. The company focuses on immuno-profiling and the discovery of novel autoantibody signatures, utilizing its SeroTag® technology to identify biomarkers that address challenges in the development of cancer immunotherapies and treatments for autoimmune conditions. Protagen is recognized for its expertise in patient stratification, having created disease-specific NavigAID panels that assess individual patients' autoimmune conditions and immune statuses. This tailored approach enables the development of more targeted therapies for various autoimmune diseases, including systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjögren’s syndrome. Additionally, Protagen's biomarker discovery platform aids in the detection of autoantibodies in patients undergoing cancer immunotherapy, which helps predict treatment responses and supports informed therapeutic decisions.

Sovicell specializes in offering advanced ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicology) products and services that facilitate the drug discovery process. The company provides bio-analytical kits designed to assess the pharmacokinetics of drug candidates and other test substances. These kits include tests for absorption, distribution, metabolism, excretion, and toxicity, enabling clients to swiftly obtain reliable and consistent pharmacokinetic data and predictions regarding potential side effects. Through its innovative solutions, Sovicell aims to enhance the efficiency and accuracy of drug development for its customers.

Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

Efficient Energy GmbH, based in Feldkirchen, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and residential applications. The company is known for its innovative eChiller, which utilizes pure water as a refrigerant, effectively eliminating the need for harmful fluorinated refrigerants. This clean compression refrigeration unit is designed for various cooling needs, including data centers, server rooms, and industrial processes, with cooling capacities ranging from 35 kW to 120 kW. In addition to its products, Efficient Energy offers a range of services, including consulting, planning, installation, and energy efficiency optimization. The company's pioneering technology has garnered recognition, receiving several awards, including the European Business Award for the Environment and recognition in the Deloitte Technology Fast 50. Efficient Energy aims to provide sustainable, efficient, and cost-effective cooling solutions to meet the growing regulatory challenges in the refrigeration industry.

Corimmun is a clinical drug development company based in Martinsried, near Munich, Germany. The company specializes in creating innovative therapeutics and diagnostics aimed at treating heart and vascular diseases, particularly those that currently have unmet medical needs. Corimmun's expertise encompasses the entire spectrum of drug development, from initial research through to commercialization, positioning it as a key player in the field of cardiovascular therapeutics.

Protagen is a precision medicine company that specializes in drug development and patient management, particularly in the fields of autoimmune diseases and immuno-oncology. The company focuses on immuno-profiling and the discovery of novel autoantibody signatures, utilizing its SeroTag® technology to identify biomarkers that address challenges in the development of cancer immunotherapies and treatments for autoimmune conditions. Protagen is recognized for its expertise in patient stratification, having created disease-specific NavigAID panels that assess individual patients' autoimmune conditions and immune statuses. This tailored approach enables the development of more targeted therapies for various autoimmune diseases, including systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjögren’s syndrome. Additionally, Protagen's biomarker discovery platform aids in the detection of autoantibodies in patients undergoing cancer immunotherapy, which helps predict treatment responses and supports informed therapeutic decisions.

SuppreMol is a private biotechnology company that specializes in developing therapeutics for autoimmune and allergic diseases. The company is dedicated to creating innovative treatments aimed at addressing the underlying causes of these disorders, rather than just alleviating their symptoms. SuppreMol's research focuses on soluble Fc-gamma receptors, which are recombinant autologous therapeutic proteins designed to possess specific immunoregulatory properties. This approach has the potential to advance the treatment landscape for individuals suffering from autoimmune conditions, offering new hope for more effective and long-lasting solutions.

Protagen is a precision medicine company that specializes in drug development and patient management, particularly in the fields of autoimmune diseases and immuno-oncology. The company focuses on immuno-profiling and the discovery of novel autoantibody signatures, utilizing its SeroTag® technology to identify biomarkers that address challenges in the development of cancer immunotherapies and treatments for autoimmune conditions. Protagen is recognized for its expertise in patient stratification, having created disease-specific NavigAID panels that assess individual patients' autoimmune conditions and immune statuses. This tailored approach enables the development of more targeted therapies for various autoimmune diseases, including systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjögren’s syndrome. Additionally, Protagen's biomarker discovery platform aids in the detection of autoantibodies in patients undergoing cancer immunotherapy, which helps predict treatment responses and supports informed therapeutic decisions.

Isarna Therapeutics is focused on developing selective TGF-β inhibitors aimed at treating ophthalmic diseases, fibrotic conditions, and cancer. The company is advancing a unique pipeline that includes novel oligonucleotides and combination therapies designed to enhance clinical responses and improve patient outcomes. Through its innovative approach, Isarna Therapeutics seeks to address significant unmet medical needs in these areas.

Sovicell specializes in offering advanced ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicology) products and services that facilitate the drug discovery process. The company provides bio-analytical kits designed to assess the pharmacokinetics of drug candidates and other test substances. These kits include tests for absorption, distribution, metabolism, excretion, and toxicity, enabling clients to swiftly obtain reliable and consistent pharmacokinetic data and predictions regarding potential side effects. Through its innovative solutions, Sovicell aims to enhance the efficiency and accuracy of drug development for its customers.

Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.

Protagen is a precision medicine company that specializes in drug development and patient management, particularly in the fields of autoimmune diseases and immuno-oncology. The company focuses on immuno-profiling and the discovery of novel autoantibody signatures, utilizing its SeroTag® technology to identify biomarkers that address challenges in the development of cancer immunotherapies and treatments for autoimmune conditions. Protagen is recognized for its expertise in patient stratification, having created disease-specific NavigAID panels that assess individual patients' autoimmune conditions and immune statuses. This tailored approach enables the development of more targeted therapies for various autoimmune diseases, including systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjögren’s syndrome. Additionally, Protagen's biomarker discovery platform aids in the detection of autoantibodies in patients undergoing cancer immunotherapy, which helps predict treatment responses and supports informed therapeutic decisions.

Isarna Therapeutics is focused on developing selective TGF-β inhibitors aimed at treating ophthalmic diseases, fibrotic conditions, and cancer. The company is advancing a unique pipeline that includes novel oligonucleotides and combination therapies designed to enhance clinical responses and improve patient outcomes. Through its innovative approach, Isarna Therapeutics seeks to address significant unmet medical needs in these areas.